U.S. flag

An official website of the United States government

NM_000546.6(TP53):c.935C>G (p.Thr312Ser) AND not provided

Germline classification:
Conflicting interpretations of pathogenicity (3 submissions)
Last evaluated:
Nov 3, 2021
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000213063.17

Allele description [Variation Report for NM_000546.6(TP53):c.935C>G (p.Thr312Ser)]

NM_000546.6(TP53):c.935C>G (p.Thr312Ser)

Gene:
TP53:tumor protein p53 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p13.1
Genomic location:
Preferred name:
NM_000546.6(TP53):c.935C>G (p.Thr312Ser)
Other names:
p.T312S:ACC>AGC
HGVS:
  • NC_000017.11:g.7673593G>C
  • NG_017013.2:g.18958C>G
  • NM_000546.6:c.935C>GMANE SELECT
  • NM_001126112.3:c.935C>G
  • NM_001126113.3:c.935C>G
  • NM_001126114.3:c.935C>G
  • NM_001126115.2:c.539C>G
  • NM_001126116.2:c.539C>G
  • NM_001126117.2:c.539C>G
  • NM_001126118.2:c.818C>G
  • NM_001276695.3:c.818C>G
  • NM_001276696.3:c.818C>G
  • NM_001276697.3:c.458C>G
  • NM_001276698.3:c.458C>G
  • NM_001276699.3:c.458C>G
  • NM_001276760.3:c.818C>G
  • NM_001276761.3:c.818C>G
  • NP_000537.3:p.Thr312Ser
  • NP_000537.3:p.Thr312Ser
  • NP_001119584.1:p.Thr312Ser
  • NP_001119585.1:p.Thr312Ser
  • NP_001119586.1:p.Thr312Ser
  • NP_001119587.1:p.Thr180Ser
  • NP_001119588.1:p.Thr180Ser
  • NP_001119589.1:p.Thr180Ser
  • NP_001119590.1:p.Thr273Ser
  • NP_001263624.1:p.Thr273Ser
  • NP_001263625.1:p.Thr273Ser
  • NP_001263626.1:p.Thr153Ser
  • NP_001263627.1:p.Thr153Ser
  • NP_001263628.1:p.Thr153Ser
  • NP_001263689.1:p.Thr273Ser
  • NP_001263690.1:p.Thr273Ser
  • LRG_321t1:c.935C>G
  • LRG_321:g.18958C>G
  • LRG_321p1:p.Thr312Ser
  • NC_000017.10:g.7576911G>C
  • NM_000546.4:c.935C>G
  • NM_000546.5(TP53):c.935C>G
  • NM_000546.5:c.935C>G
  • P04637:p.Thr312Ser
  • p.T312S
Protein change:
T153S
Links:
UniProtKB: P04637#VAR_045488; dbSNP: rs145151284
NCBI 1000 Genomes Browser:
rs145151284
Molecular consequence:
  • NM_000546.6:c.935C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126112.3:c.935C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126113.3:c.935C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126114.3:c.935C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126115.2:c.539C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126116.2:c.539C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126117.2:c.539C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126118.2:c.818C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276695.3:c.818C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276696.3:c.818C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276697.3:c.458C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276698.3:c.458C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276699.3:c.458C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276760.3:c.818C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276761.3:c.818C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided; RECLASSIFIED - ADRA2C POLYMORPHISM; RECLASSIFIED - ADRB1 POLYMORPHISM
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000211763GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Uncertain significance
(Jan 18, 2018)
germlineclinical testing

Citation Link,

SCV001134881Quest Diagnostics Nichols Institute San Juan Capistrano
criteria provided, single submitter

(Quest Diagnostics criteria)
Likely benign
(Oct 29, 2020)
unknownclinical testing

PubMed (10)
[See all records that cite these PMIDs]

SCV002011360Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Nov 3, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlinenot providednot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families.

Bougeard G, Sesboüé R, Baert-Desurmont S, Vasseur S, Martin C, Tinat J, Brugières L, Chompret A, de Paillerets BB, Stoppa-Lyonnet D, Bonaïti-Pellié C, Frébourg T; French LFS working group.

J Med Genet. 2008 Aug;45(8):535-8. doi: 10.1136/jmg.2008.057570. Epub 2008 May 29.

PubMed [citation]
PMID:
18511570

Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis.

Kato S, Han SY, Liu W, Otsuka K, Shibata H, Kanamaru R, Ishioka C.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8424-9. Epub 2003 Jun 25.

PubMed [citation]
PMID:
12826609
PMCID:
PMC166245
See all PubMed Citations (11)

Details of each submission

From GeneDx, SCV000211763.14

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is denoted TP53 c.935C>G at the cDNA level, p.Thr312Ser (T312S) at the protein level, and results in the change of a Threonine to a Serine (ACC>AGC). This variant has been observed in at least one individual with a personal and/or family history suggestive of Li-Fraumeni syndrome (Bougeard 2008). Additionally, TP53 Thr312Ser has been identified in an individual with a head and neck cancer and in an individual with pancreatic cancer (Mafune 2015, Yang 2016). This variant is reported as having functional transactivation in the International Agency for Research on Cancer TP53 database based on functional assays by Kato et al. (2003). TP53 Thr312Ser was observed at an allele frequency of 0.029% (7/24028) in individuals of African ancestry in large population cohorts (Lek 2016). TP53 Thr312Ser is not located within a known functional domain. In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function. Based on currently available evidence, it is unclear whether TP53 Thr312Ser is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV001134881.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (10)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden, SCV002011360.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 30, 2024